Exper Perspectives Logo
  • Home
  • Therapeutic Categories
    • BACK
    • Therapeutic Categories
    • Allergy & Immunology
      • BACK
      • Allergy & Immunology
      • Chronic Spontaneous Urticaria
      • Food Allergies
      • Pediatric Food Allergies
    • Dermatology
      • BACK
      • Dermatology
      • Atopic Dermatitis
      • Plaque Psoriasis
    • Endocrinology
      • BACK
      • Endocrinology
      • Type 2 Diabetes
    • Gastroenterology
      • BACK
      • Gastroenterology
      • Crohn's Disease
      • Ulcerative Colitis
    • Hematology
      • BACK
      • Hematology
      • Chronic Immune Thrombocytopenia
      • Paroxysmal Nocturnal Hemoglobinuria
      • Sickle Cell Disease
    • Hepatology
      • BACK
      • Hepatology
      • Liver Fibrosis
    • Infectious Diseases
      • BACK
      • Infectious Diseases
      • Adolescent Vaccinations
      • Adult Vaccinations
      • Influenza
    • Nephrology
      • BACK
      • Nephrology
      • IgAN
      • IgAN & C3G
    • Neurology
      • BACK
      • Neurology
      • Alzheimer's Disease
      • Epilepsy
      • Generalized Myasthenia Gravis
      • Insomnia
      • Migraine
      • Multiple Sclerosis
      • Relapsing Multiple Sclerosis
      • Spinal Muscular Atrophy
      • Tuberous Sclerosis Complex
    • Oncology
      • BACK
      • Oncology
      • Acute Myeloid Leukemia
      • Advanced Prostate Cancer
      • Advanced ROS1-positive NSCLC
      • Anemia in MDS
      • Carcinoid Syndrome
      • Chronic Graft-versus-Host Disease
      • Chronic Lymphocytic Leukemia
      • Chronic Myeloid Leukemia
      • Endometrial Cancer
      • Gastroenteropancreatic Neuroendocrine Tumors
      • Gastrointestinal Stromal Tumors
      • HER2+ Breast Cancer
      • HR+ HER2- Breast Cancer
      • HR+/HER2- Early Breast Cancer
      • Locally Advanced Basal Cell Carcinoma
      • Mantle Cell Lymphoma
      • Melanoma
      • Metastatic Breast Cancer
      • Metastatic Pancreatic Cancer
      • Multiple Myeloma
      • Myelofibrosis
      • Myeloproliferative Neoplasms
      • Non-Small Cell Lung Cancer
      • Prostate Cancer
      • PSMA+ mCRPC
      • Relapsed/Refractory Diffuse Large B-Cell Lymphoma
      • Relapsed/Refractory Multiple Myeloma
    • Ophthalmology
      • BACK
      • Ophthalmology
      • Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    • Osteoporosis
      • BACK
      • Osteoporosis
      • Osteoporosis
    • Psychiatry
      • BACK
      • Psychiatry
      • Major Depressive Disorder
      • Schizophrenia
      • Tardive Dyskinesia
    • Pulmonology
      • BACK
      • Pulmonology
      • Asthma
      • Chronic Obstructive Pulmonary Disease
      • Interstitial Lung Disease
    • Rheumatology
      • BACK
      • Rheumatology
      • Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
  • Conference Reporter
  • Expert Directory
  • About Expert Perspectives
  • Login/Register

experspadmin

Impact of Obesity and Comorbidity on Biologic Therapy Effectiveness
Rheumatology

Impact of Obesity and Comorbidity on Biologic Therapy Effectiveness

patient care perspectives
By Jeffrey R. Curtis, MD, MS, MPH
Achieving Remission in Patients With Rheumatoid Arthritis Who Have Failed Previous Therapies
Rheumatology

Achieving Remission in Patients With Rheumatoid Arthritis Who Have Failed Previous Therapies

patient care perspectives
By Leonard H. Calabrese, DO
Use of Prognostic Factors to Guide the Treatment of Patients With Mantle Cell Lymphoma
Oncology

Use of Prognostic Factors to Guide the Treatment of Patients With Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Julie M. Vose, MD, MBA, FASCO; Thomas J. Kipps, MD, PhD
Treatment Options for Patients With Early Relapse of Mantle Cell Lymphoma
Oncology

Treatment Options for Patients With Early Relapse of Mantle Cell Lymphoma

expert roundtables
By Brad Kahl, MD; Julie M. Vose, MD, MBA, FASCO; Thomas J. Kipps, MD, PhD
Potential Use of Bispecific Antibodies Designed to Target CD20 on B Cells and CD3 on T Cells
Oncology

Potential Use of Bispecific Antibodies Designed to Target CD20 on B Cells and CD3 on T Cells

clinical topic updates
By Julie M. Vose, MD, MBA, FASCO
Load More   
logo 2026 Expert Perspectives®
Privacy Policy     Terms of Service     About Expert Perspectives

Your California Privacy Rights     Do Not Sell My Personal Information
Login Expert Perspectives
Forgot Password?
or Create an Account
Create an Account
Forgot Password?